Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Glioblastoma Remote Monitoring and Care - Research Protocol

NCT: NCT06129760 · SUSPENDED

NCT IDNCT06129760
StatusSUSPENDED
Start Date2024-04-30
Completion2027-12

Brief Summary

The purpose of this research is to learn more about how what the Apple watch measures, in terms of walking data, heart rate, breathing rate, and sleep habits, relates to how participants feel. During the course of the treatment, the symptoms participants experience change, and whether the Apple watch can detect these changes. Ultimately, this knowledge is being used to design proactive tools and signatures that can predict complications or symptom changes before they happen.

Frequently Asked Questions

What is Glioblastoma Remote Monitoring and Care - Research Protocol?

Glioblastoma Remote Monitoring and Care - Research Protocol is a clinical trial registered under NCT06129760. Current status: SUSPENDED.

What is the status of NCT06129760?

The current status of NCT06129760 (Glioblastoma Remote Monitoring and Care - Research Protocol) is: SUSPENDED.

When did Glioblastoma Remote Monitoring and Care - Research Protocol start?

Glioblastoma Remote Monitoring and Care - Research Protocol started on 2024-04-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.